Forty-eight novel mutations causing biotinidase deficiency.

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Biotinidase deficiency is an inherited metabolic disorder impacting biotin recycling.
• Characterized by neurological and cutaneous symptoms, it can be managed with biotin supplementation.
• Early diagnosis and genetic analysis are crucial for effective patient counseling and management.

Purpose of the Study:

• To identify and characterize novel mutations in the biotinidase gene.
• To correlate genotype with serum enzyme activity to determine mutation pathogenicity.
• To enhance a clinical database for improved patient management and genetic counseling.

Main Methods:

• Analysis of approximately 300 patient samples for biotinidase gene mutations.
• Identification of 48 novel genetic alterations.
• Correlation of identified genotypes with measured serum biotinidase enzyme activity.

Main Results:

• 48 novel alterations in the biotinidase gene were identified.
• The pathogenicity of novel mutations was determined for 44 individuals by correlating genotype with enzyme activity.
• A database of mutations was updated to aid clinical decision-making.

Conclusions:

• Genetic analysis of the biotinidase gene is essential for understanding disease mechanisms.
• Novel mutations can be assessed for pathogenicity by correlating genotype with enzyme activity.
• An updated mutation database aids clinicians in managing biotinidase deficiency and counseling patients.